Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis

K. Liang,J.L. Feliciano,K.A. Marrone, J.C. Murray, C.L. Hann,V. Anagnostou, S.A. Tackett, E.J. Shin,R.K. Hales,K.R. Voong,R.J. Battafarano, S.C. Yang,S.R. Broderick, J.S. Ha,P.M. Forde,J.R. Brahmer,V.K. Lam

ESMO Open（2024）

Cited 0|Views5
No score
Abstract
•HER2 overexpression carries increased BRM risk in E/GEJ cancer.•Trastuzumab therapy improves clinical outcomes in HER2+ E/GEJ patients with BRM.•Prevalence of solitary/asymptomatic BRMs suggests role for enhanced surveillance.
More
Translated text
Key words
esophageal cancer,gastroesophageal junction cancer,HER2 overexpression,brain metastasis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined